熱門資訊> 正文
Immunic宣布1比10反向股票拆分
2026-04-23 21:02
- Immunic (IMUX) will effect a reverse stock split of its outstanding shares of common stock, effective April 27, 2026.
- The reverse stock split is primarily intended to allow Immunic to meet its contractual obligations under the securities purchase agreement entered into between the company and certain institutional and accredited investors on February 12, 2026.
- IMUX -4.42% premarket to $0.8602.
- Source: Press Release
More on Immunic
- Immunic, Inc. (IMUX) Presents at 8th Annual Neuroimmunology Drug Development Summit - Slideshow
- Immunic garners new Buy at Guggenheim on lead asset
- Immunic rises after $400M private placement, leadership transition
- Seeking Alpha’s Quant Rating on Immunic
- Historical earnings data for Immunic
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。